GoodRx Stock Forecast
NASDAQ: GDRXTechnologyEDP ServicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
GDRX analyst consensus
Consensus (14 analysts)
hold
Avg. price target
$3.95+17.56%
- Strong buy 1
- Buy 3
- Hold 8
- Sell 0
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 14 Wall Street analysts covering GoodRx (2026-10-08), 4 rate the stock a buy or strong buy, 8 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $3.95, with a high estimate of $5.00 and a low estimate of $2.65. The average target implies upside of 17.6% from the current price of $3.36.
The spread between the highest and lowest targets is 88.7%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for GDRX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 7% |
| Buy | 3 | 21% |
| Hold | 8 | 57% |
| Sell | 0 | 0% |
| Strong sell | 2 | 14% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $2.65 | -21.13% |
| Average target | $3.95 | +17.56% |
| High target | $5.00 | +48.81% |